Wang ZH, Zhou L, Wang CF, Zhang LF. Clinical significance of expression of miR-143 in pancreatic carcinoma.
Shijie Huaren Xiaohua Zazhi 2016;
24:1520-1525. [DOI:
10.11569/wcjd.v24.i10.1520]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
AIM: To investigate the expression of miR-143 in human pancreatic ductal adenocarcinoma (PDAC) and to explore the relation between miRNA-143 expression and prognosis of patients with PDAC.
METHODS: We collected 70 PDAC specimens from patients treated at the First Affiliated Hospital of Zhengzhou University, including cancer tissues and paired cancer-adjacent tissues. The expression of miR-143 was examined by locked nucleic acids-in situ hybridization (LNA-ISH). Then the relation between the expression of miR-143 and clinical parameters was analyzed with SPSS16.0.
RESULTS: The expression rate of miR-143 was lower in cancerous tissues than in paired non-cancerous pancreatic tissues (25.71% vs 68.57%, P = 0.001). The expression of miR-143 in cancerous tissues was associated with lymph node metastasis (P = 0.045). The median survival of patients with low miR-143 expression was significantly shorter than that of patients with high miR-143 expression (P = 0.026).
CONCLUSION: The expression of miR143 is low in cancer tissue, and its low expression is associated with poor prognosis in patients with PDAC.
Collapse